Acute myeloid leukaemia (AML) genetic mutation IVD, kit, nucleic acid technique (NAT)
United Kingdom·In Vitro Diagnostic Device·PentaBase A/S·Registered Nov 26, 2024- Device ID
- 169679
- MHRA Reference Number
- 169679
- Date Registered
- Nov 26, 2024
- Last Updated
- Mar 22, 2024
- Device Type
- In Vitro Diagnostic Device
- Devices
- Acute myeloid leukaemia (AML) genetic mutation IVD, kit, nucleic acid technique (NAT)
- Type
- IVD General
- Name
- PentaBase A/S
- Address
- Petersmindevej 1A Odense C, Denmark
- Created Date
- Mar 29, 2023
- Relationship Type
- UK Responsible Person
- Address
- Office 32 19-21 Crawford Street London, United KingdomPostcode: W1H 1PJ
Devices with a matching generic name or device type registered with MHRA
Additional devices registered by the same manufacturer
Additional devices represented by CMC Medical Devices LTD in the UK
Acute myeloid leukaemia (AML) genetic mutation IVD, kit, nucleic acid technique (NAT) is a medical device registered with the UK's Medicines and Healthcare products Regulatory Agency (MHRA) under Device ID 169679. The device is manufactured by PentaBase A/S from Denmark, classified as In Vitro Diagnostic Device. The authorized representative in the UK is CMC Medical Devices LTD.
This page provides comprehensive regulatory information including complete registration details, manufacturer information, device classification, authorized representative details, and related products. Pure Global AI offers free access to 150,962+ UK MHRA medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.